Select Medical (NYSE:SEM) Earns Sell (D+) Rating from Weiss Ratings

Key Points

• Select Medical's stock has been given a "sell (D+)" rating by Weiss Ratings, despite mixed opinions from other analysts.
• Royal Bank of Canada raised its price target for the stock to $20.00, while Bank of America lowered theirs to $15.00, indicating differing market outlooks.
• The company reported a net margin of 2.37% and revenue of $1.34 billion in its last quarterly earnings, reflecting a 4.5% year-over-year increase.

Select Medical (NYSE:SEM - Get Free Report)'s stock had its "sell (d+)" rating reiterated by investment analysts at Weiss Ratings in a note issued to investors on Friday,Weiss Ratings reports.

SEM has been the subject of several other research reports. Royal Bank Of Canada boosted their price objective on Select Medical from $16.00 to $20.00 and gave the stock an "outperform" rating in a report on Wednesday, October 8th. Bank of America cut their price objective on Select Medical from $18.00 to $15.00 and set a "buy" rating for the company in a report on Wednesday, September 10th. Finally, UBS Group reissued a "neutral" rating and set a $14.00 price objective (down previously from $15.00) on shares of Select Medical in a report on Monday, August 4th. Four investment analysts have rated the stock with a Buy rating, one has given a Hold rating and one has issued a Sell rating to the company's stock. According to data from MarketBeat, Select Medical has a consensus rating of "Moderate Buy" and an average target price of $19.40.

Select Medical Trading Up 0.2%

Shares of SEM opened at $14.30 on Friday. The business's 50-day moving average price is $13.06 and its 200-day moving average price is $14.30. Select Medical has a twelve month low of $11.65 and a twelve month high of $40.98. The stock has a market cap of $1.77 billion, a PE ratio of 13.49, a P/E/G ratio of 0.58 and a beta of 1.28. The company has a quick ratio of 1.15, a current ratio of 1.15 and a debt-to-equity ratio of 0.92.

Select Medical (NYSE:SEM - Get Free Report) last issued its quarterly earnings data on Thursday, July 31st. The health services provider reported $0.32 EPS for the quarter, topping the consensus estimate of $0.28 by $0.04. Select Medical had a return on equity of 8.87% and a net margin of 2.37%.The company had revenue of $1.34 billion during the quarter, compared to analyst estimates of $1.35 billion. During the same quarter in the previous year, the firm earned $0.60 earnings per share. Select Medical's revenue was up 4.5% on a year-over-year basis. Select Medical has set its FY 2025 guidance at 1.090-1.19 EPS. On average, equities analysts forecast that Select Medical will post 1.17 EPS for the current fiscal year.

Institutional Trading of Select Medical

Several hedge funds and other institutional investors have recently bought and sold shares of the company. 8 Knots Management LLC bought a new stake in Select Medical in the second quarter valued at approximately $26,568,000. Nuveen LLC bought a new stake in Select Medical in the first quarter valued at approximately $12,133,000. Vanguard Group Inc. lifted its position in Select Medical by 4.7% in the first quarter. Vanguard Group Inc. now owns 13,316,069 shares of the health services provider's stock valued at $222,378,000 after purchasing an additional 603,079 shares during the last quarter. Voya Investment Management LLC lifted its position in Select Medical by 48.7% in the first quarter. Voya Investment Management LLC now owns 1,507,349 shares of the health services provider's stock valued at $25,173,000 after purchasing an additional 493,983 shares during the last quarter. Finally, Bridgeway Capital Management LLC lifted its position in Select Medical by 43.1% in the first quarter. Bridgeway Capital Management LLC now owns 1,068,658 shares of the health services provider's stock valued at $17,847,000 after purchasing an additional 322,035 shares during the last quarter. Hedge funds and other institutional investors own 89.48% of the company's stock.

About Select Medical

Select Medical Holdings Corporation, through its subsidiaries, operates critical illness recovery hospitals, rehabilitation hospitals, outpatient rehabilitation clinics, and occupational health centers in the United States. It operates in four segments: Critical Illness Recovery Hospital, Rehabilitation Hospital, Outpatient Rehabilitation, and Concentra.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.